Saturday, July 11, 2026

pharma · No medical condition. · Generalized Myasthenia Gravis

Anaxis Pharma

Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial

Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
7
Programs
642
Drugs
673
Patents
0
Clinical program

R5458-668-ALG-2219

Phase 1 · other · Severe IgE-mediated food allergy

R5458-668-ALG-2219 for Severe IgE-mediated food allergy is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Internal code R5458-668-ALG-2219

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Lacuna Pharma Pty Ltd
Phase
Phase 1
Modality
other
Indication
Severe IgE-mediated food allergy
Status
active
Trials
1